Combination medicine for preventing/treating dyslipidemia or cardiovascular disease
AssigneeKowa Company, Ltd.
InventorsNoriyuki INOUE, Kenji SAITO, Toshiaki TAKIZAWA
Life of this patent
Estimating the term…
Loading patent…
AssigneeKowa Company, Ltd.
InventorsNoriyuki INOUE, Kenji SAITO, Toshiaki TAKIZAWA
Estimating the term…
The present invention addresses the problem of providing a pharmaceutical composition/drug combination which makes it possible to prevent and/or treat dyslipidemia such as hypercholesterolemia and hypertriglyceridemia, or cardiovascular diseases such as arteriosclerosis and cardiovascular events. The present invention provides a combination of a peroxisome proliferator-activated receptor (PPAR) α agonist and an ATP citrate lyase (ACL) inhibitor for preventing and/or treating dyslipidemia such as hypercholesterolemia and hypertriglyceridemia, or cardiovascular diseases such as arteriosclerosis and cardiovascular events.
-5. (canceled)
A method for preventing and/or treating dyslipidemia or cardiovascular disease, comprising:
Dependencies are inferred from the claim text.